Research location
Gilly
Belgium
Advertisement
Research activity in Gilly
BelgiumCureCurrent currently publishes aggregate city-level research activity for this location: 71 trials and 71 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Gilly
71 linked trials · page 2 of 2A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung CancerNCT00789373 · 2008-11-01 · 1 site observation
COMPLETED
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung CancerNCT00686959 · 2008-09-01 · 1 site observation
COMPLETED
A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and EtoposideNCT00759824 · 2008-09-01 · 1 site observation
COMPLETED
Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.NCT00759382 · 2008-07-01 · 1 site observation
UNKNOWN
CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)NCT00681122 · 2008-05-01 · 1 site observation
COMPLETED
An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung CancerNCT01161173 · 2008-04-01 · 1 site observation
COMPLETED
OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.NCT00681850 · 2008-03-01 · 1 site observation
COMPLETED
Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary PreventionNCT00689377 · 2007-05-01 · 1 site observation
COMPLETED
Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).NCT00523991 · 2007-04-01 · 1 site observation
COMPLETED
Local Phase 4 Pan-European SMART StudyNCT00463866 · 2007-03-01 · 1 site observation
COMPLETED
Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung CancerNCT00633568 · 2007-01-01 · 1 site observation
TERMINATED
Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction ChemotherapyNCT00661011 · 2007-01-01 · 1 site observation
TERMINATED
Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid ArthritisNCT00420927 · 2006-12-01 · 1 site observation
COMPLETED
Phase II Study of Valproate and Doxorubicin in Malignant MesotheliomaNCT00634205 · 2006-07-01 · 1 site observation
COMPLETED
Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)NCT00313209 · 2006-04-01 · 1 site observation
COMPLETED
SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent AsthmaNCT00290264 · 2004-12-01 · 1 site observation
COMPLETED
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00949910 · 2004-11-01 · 1 site observation
COMPLETED
Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung CancerNCT00192036 · 2004-08-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic CancerNCT00541281 · 2003-12-01 · 1 site observation
COMPLETED
Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesNCT00604396 · 2003-03-01 · 1 site observation
COMPLETED
CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.NCT00479739 · 2002-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.